Now showing items 1-6 of 6

    • Controlled release vaccines and methods of treating Brucella diseases and disorders 

      Ficht, Thomas A.; Ficht, Allison; Tsolis, Renee; Garry Adams, Leslie (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2019-03-05)
      Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
    • Controlled release vaccines and methods of treating Brucella diseases and disorders 

      Ficht, Thomas A.; Ficht, Allison; Tsolis, Renee; Garry Adams, Leslie (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2019-03-05)
      Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
    • HSP20 inhibits amyloidogenesis and neurotoxicity 

      Ficht, Allison; Good, Theresa; Carson, Kenneth; Lee, Sungmun (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2016-04-26)
      The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    • HSP20 inhibits amyloidogenesis and neurotoxicity 

      Ficht, Allison; Good, Theresa; Carson, Kenneth; Lee, Sungmun (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2017-10-31)
      The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    • HSP20 inhibits amyloidogenesis and neurotoxicity 

      Ficht, Allison; Good, Theresa; Carson, Ken; Lee, Sundmun (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2014-04-29)
      The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    • A Study of the Process and Causes of Abeta(25-35) Amyloid Formation 

      Ridinger, Katherine V. (2011-02-22)
      Amyloid fibrils results from a type of ordered polypeptide aggregation that is associated with ailments such as Alzheimer's disease (AD). Annually, millions of people in the United States alone develop and die from AD. ...